Novartis Fabhalta gets positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria Ruchika Sharma24 March 2024 2:30 PM ISTBasel: Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...
Sanofi gets European Commission nod for hemolytic anemia drug Enjaymo Ruchika Sharma19 Nov 2022 12:30 PM ISTEnjaymo is a humanized monoclonal antibody that is designed to selectively target and inhibit C1s in the classical complement pathway, which is part...
Sanofi gets EMA Committee recommendation for approval of Enjaymo for hemolytic anemia in adult patients with cold agglutinin disease Ruchika Sharma18 Sept 2022 10:45 AM ISTParis: Sanofi has recently announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted...
Mitapivat improves Hb, decreases hemolysis in pyruvate kinase deficiency: NEJM Medha Baranwal15 April 2022 9:45 AM ISTUSA: Mitapivat significantly increases the hemoglobin level, improves patient-reported outcomes, and decreases hemolysis in patients with pyruvate...
Chronic atrophic gastritis as rare cause and manifestation of vitamin B12 deficiency: Case report MD Editorial Team28 Aug 2021 9:00 AM ISTUSA: Researchers have reported a rare case of chronic atrophic gastritis presenting as hemolytic anemia due to severe vitamin B12 deficiency, which...
Ceftriaxone may cause immune hemolytic anaemia in pediatric patients Dr. Kamal Kant Kohli15 March 2020 5:30 PM ISTAccording to a new systematic review, ceftriaxone may give rise to the most serious adverse drug reaction of immune hemolytic anaemia in pediatric...
